Manoj K Kashyap Selected Research

FD 895

1/2022	Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B.
7/2015	Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manoj K Kashyap Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 06/2013
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 07/2015
2	Carcinogenesis 01/2020 - 11/2015
2	Hematologic Neoplasms (Hematological Malignancy) 04/2018 - 01/2016
2	Adenocarcinoma of Lung 01/2017 - 09/2008
2	Leukemia 01/2016 - 07/2015
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Inflammation (Inflammations) 01/2019
1	Barrett Esophagus (Barrett's Esophagus) 01/2019
1	Esophageal Squamous Cell Carcinoma 04/2018
1	Lymphoma (Lymphomas) 07/2015
1	Stomach Neoplasms (Stomach Cancer) 06/2013
1	Adenocarcinoma 06/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2012
1	Lung Neoplasms (Lung Cancer) 09/2008
1	Essential Hypertension 09/2005

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2008
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2012
2	FD 895IBA 01/2022 - 07/2015
2	pladienolide BIBA 01/2022 - 07/2015
2	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 09/2008
1	Messenger RNA (mRNA)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	EnzymesIBA 01/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019
1	Angiotensin IIBA 01/2019
1	Angiotensin IIIBA 01/2019
1	candesartanIBA 01/2019
1	Enalapril FDA LinkGeneric 01/2019
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 04/2018
1	Syk KinaseIBA 04/2018
1	AfatinibIBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Bendamustine Hydrochloride FDA Link 01/2017
1	Gefitinib (Iressa)FDA Link 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	LigandsIBA 01/2016
1	ulocuplumabIBA 01/2016
1	CXC ChemokinesIBA 01/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2016
1	Insulin-Like Growth Factor Binding ProteinsIBA 11/2015
1	MacrolidesIBA 07/2015
1	AntigensIBA 11/2012
1	Epithelial Cell Adhesion MoleculeIBA 11/2012
1	Serine Proteases (Serine Protease)IBA 11/2012
1	IsotopesIBA 09/2008
1	Amino Acids FDA Link 09/2008
1	Free RadicalsIBA 09/2005
1	AntioxidantsIBA 09/2005

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
2	Therapeutics 01/2017 - 07/2015